Articles From: IGI Laboratories To Hold Conference Call For 2nd Quarter 2014 Results to IGT Expands Powerbucks® Jackpot Pool to Nevada


2014/7/18
BUENA, N.J. , July 18, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call at 4:15 pm ET on Thursday, July 24, 2014 to discuss the 2nd quarter 2014 results.
Sign-up for IGI Laboratories To Hold Conference Call For 2nd Quarter 2014 Results investment picks
BUENA, N.J. , June 20, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted two additional abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA), which brings the Company's total number of ANDA submissions in 2014 to six, with seventeen submissions now pending at the FDA.
Sign-up for IGI Laboratories, Inc. Announces 18th and 19th ANDA Submissions investment picks
2014/7/24
BUENA, N.J. , July 24, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has accepted Damian Finio's resignation from its Board of Directors.
Sign-up for IGI Laboratories, Inc. Announces Change To Its Board Of Directors investment picks
BUENA, N.J. , June 19, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted another abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA), which brings the Company's total number of ANDA submissions in 2014 to four, with fifteen submissions now pending at the FDA.
Sign-up for IGI Laboratories, Inc. Announces Fourth ANDA Submission In 2014 investment picks
BUENA, N.J. , June 26, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced that it has entered into an agreement with Mallinckrodt LLC, Mallinckrodt Inc., and Nuvo Research, Inc. (TSX: NRI) (together Mallickrodt) to settle a declaratory judgment action brought by IGI, concerning IGI's filing of an abbreviated new drug application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market a generic version of PENNSAID (diclofenac sodium topical solution) 1.5% w/w. Under the terms of this agreement, Mallinckrodt granted IGI a non-exclusive license to launch its diclofenac sodium topical solution 1.5% product on March 28 , 2015.
Sign-up for IGI Laboratories, Inc. Announces Joint Stipulation investment picks
BUENA, N.J. , June 18, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted its third abbreviated new drug application (ANDA) in 2014 to the U.S. Food and Drug Administration (FDA), which brings the Company's total number of ANDA submissions to sixteen, with fourteen now pending at the FDA.
Sign-up for IGI Laboratories, Inc. Announces Sixteenth ANDA Submission investment picks
2014/8/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0960797001&sourceType=1 http://www.ccnmatthews.com/logos/20050803-IGMfinancial.jpg WINNIPEG, MANITOBA --
Sign-up for IGM Financial Inc. Reports Second Quarter Earnings investment picks
2014/8/4
Ziff Davis, the digital media company with market-leading positions in the technology, gaming and men’s lifestyle markets, has announced three new partnerships with regional media publishing houses to bring IGN.com, the world’s leading games entertainment and fan culture destination, to three new markets – Spanish-speaking Latin America, Portugal and Greece – bringing IGN’s total global footprint to 20 international editions in 15 languages, spanning more than 90 different countries around the world and reaching a global audience of 55 million unique users per month (Google Analytics, June 2014). Ziff Davis is the Digital Media Division of j2 Global, Inc.(NASDAQGS: JCOM). IGN Latin America will be operated by Mexico-based Publimetro Mexico, a division of Metro International and publisher of Publimetro, a newspaper distributed throughout Latin America.
Sign-up for IGN Continues Rapid Global Expansion as Ziff Davis Announces IGN Latin America, IGN Portugal and IGN Greece investment picks
Ignite Restaurant Group (NASDAQ:IRG) today announced that it successfully closed on a new $195 million senior secured credit facility.
Sign-up for Ignite Restaurant Group Announces New $195 Million Credit Facility investment picks
Ignite Restaurant Group (Nasdaq:IRG), today announced the appointment of Shauna Ryan King to its Board of Directors, effective August 14, 2014.
Sign-up for Ignite Restaurant Group Appoints Shauna Ryan King to Board of Directors investment picks
Ignite Restaurant Group (NASDAQ:IRG) today reported financial results for the second quarter ended June 30, 2014.
Sign-up for Ignite Restaurant Group Reports Second Quarter 2014 Financial Results investment picks
Ignite Restaurant Group, Inc. (NASDAQ:IRG) today announced that it will host a conference call to discuss second quarter 2014 financial results on Thursday, August 7, 2014 at 5:00 PM Eastern Time.
Sign-up for Ignite Restaurant Group, Inc. to Announce Second Quarter 2014 Results on August 7, 2014 investment picks
Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, and Nerviano Medical Sciences, S.r.l., a leading oncology discovery organization, today announced that they have signed a license agreement that grants Ignyta exclusive global development and commercialization rights to two new drug development programs, which Ignyta will refer to as RXDX-103 and RXDX-104.
Sign-up for Ignyta and Nerviano Announce License Agreement for Two First-in-Class Kinase Inhibitors investment picks
Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced the multicenter initiation of the company’s global Phase I/II clinical trial of RXDX-101, its proprietary oral tyrosine kinase inhibitor targeting multiple solid tumor indications.
Sign-up for Ignyta Announces Initiation of STARTRK-1 Global Phase I/II Clinical Trial of RXDX-101 investment picks
Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced that interim results from the first-in-human ALKA-372-001 Phase I clinical trial of RXDX-101, the company’s proprietary oral tyrosine kinase inhibitor targeting solid tumor indications, was selected for presentation in a poster discussion session at the 2014 Congress of the European Society for Medical Oncology (ESMO), which is being held from September 26-30, 2014 in Madrid, Spain.
Sign-up for Ignyta Announces RXDX-101 Phase I Data Presentation at the 2014 ESMO Congress investment picks
Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced company highlights and financial results for the second quarter ended June 30, 2014.
Sign-up for Ignyta Announces Second Quarter 2014 Company Highlights and Financial Results investment picks
Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that Adrian Senderowicz, M.D., has been appointed as Chief Medical Officer and Senior Vice President, Clinical Development and Regulatory Affairs.
Sign-up for Ignyta Appoints Adrian Senderowicz, M.D., as Chief Medical Officer and Senior Vice President, Clinical Development and Regulatory Affairs investment picks
Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that Robert Wild, Ph.D., has been appointed as Chief Scientific Officer and Senior Vice President, Research.
Sign-up for Ignyta Appoints Robert Wild, Ph.D., as Chief Scientific Officer and Senior Vice President, Research investment picks
Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced that the company’s shares will be added to the Russell Microcap® Index following Russell Investments’ reconstitution of its comprehensive set of U.S. and global equity indexes after market close on June 27, 2014, according to a preliminary list of additions posted June 13, 2014 on www.russell.com /indexes .
Sign-up for Ignyta to be Added to Russell Microcap® Index investment picks
Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that it will release its second quarter 2014 financial results after the market closes on Tuesday, August 12, 2014.
Sign-up for Ignyta to Report 2014 Second Quarter Company Highlights and Financial Results and Host Conference Call on August 12, 2014 investment picks
2014/7/17
iGo, Inc. (OTC PINK: IGOI) (the “Company” or “iGo”) announced today that it has received approval from the Financial Industry Regulatory Authority ("FINRA") clearing the reverse and forward stock splits of the Company’s common stock previously approved by its stockholders and announced on June 25, 2014.
Sign-up for iGo, Inc. Announces FINRA Approval of Reverse/Forward Stock Splits investment picks
2014/6/25
LOS GATOS, Calif.
Sign-up for iGo, Inc. Announces Reverse/Forward Stock Split investment picks
STRATFORD, Conn.
Sign-up for Igor Sikorsky's VS-300 Helicopter Transformed Aviation 75 Years Ago investment picks
LAS VEGAS , Aug.
Sign-up for IGT and LT Game Form Partnership to Expand Game Distribution investment picks
LAS VEGAS , July 22, 2014 /PRNewswire/ -- The saying "Happy Friday" took on a new meaning for one southern Nevada resident after his gaming experience on global gaming entertainment leader IGT's (NYSE: IGT) famed MegaJackpots® game, Wheel Of Fortune made him $1,784,972 richer at the California Hotel & Casino Las Vegas on July 11, 2014 .
Sign-up for IGT And Wheel Of Fortune® Slots Dish Out Mega $1.7 Million Jackpot At Las Vegas Casino investment picks
LAS VEGAS , Sept.
Sign-up for IGT Brings Las Vegas-Style Excitement and Innovation to Croc's Casino Costa Rica investment picks
Transaction Combines Leading Global Gaming Content and Equipment Supplier with Leading Global Lottery Business LAS VEGAS , July 16, 2014 /PRNewswire/ -- International Game Technology (NYSE:IGT) , today announced that it has entered into a definitive merger agreement with GTECH S.p.A. for the acquisition of IGT by GTECH for $6.4 billion , comprised of $4.7 billion in cash and stock and the assumption of $1.7 billion in net debt.
Sign-up for IGT Enters into Definitive Merger Agreement with GTECH S.p.A. investment picks
Joins New Jersey and South Dakota in multi-state Wide Area Progressive link LAS VEGAS , Aug.
Sign-up for IGT Expands Powerbucks® Jackpot Pool to Nevada investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: IGI Laboratories To Hold Conference Call For 2nd Quarter 2014 Results to IGT Expands Powerbucks® Jackpot Pool to Nevada
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices